MOLDS, RUSTS AND SMUTS, EPIDERMOPHYTON FLOCCOSUM- epidermophyton floccosum injection, solution
MOLDS, RUSTS AND SMUTS, FUSARIUM 美国 - 英文 - NLM (National Library of Medicine)

molds, rusts and smuts, epidermophyton floccosum- epidermophyton floccosum injection, solution molds, rusts and smuts, fusarium

jubilant hollisterstier llc - epidermophyton floccosum (unii: 6jr6jtn25s) (epidermophyton floccosum - unii:6jr6jtn25s) - epidermophyton floccosum 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

MOLDS, RUSTS AND SMUTS, CANDIDA ALBICANS- candida albicans injection, solution
MOLDS, RUSTS AND SMUTS, CEPHALOSPORIUM ACREMONIU 美国 - 英文 - NLM (National Library of Medicine)

molds, rusts and smuts, candida albicans- candida albicans injection, solution molds, rusts and smuts, cephalosporium acremoniu

jubilant hollisterstier llc - candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc) - candida albicans 0.1 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the

ANIMAL ALLERGENS, AP HORSE HAIR AND DANDER- ap horse hair and dander injection, solution
ANIMAL ALLERGENS, AP CATTLE HAIR AND D 美国 - 英文 - NLM (National Library of Medicine)

animal allergens, ap horse hair and dander- ap horse hair and dander injection, solution animal allergens, ap cattle hair and d

jubilant hollisterstier llc - equus caballus hair (unii: 4f35xg0149) (equus caballus hair - unii:4f35xg0149), equus caballus dander (unii: j81sz18495) (equus caballus dander - unii:j81sz18495) - equus caballus hair 0.0005 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established.15 in addition to a carefully taken history, the use of intradermal testing extracts is an accepted method in the diagnosis of allergenic conditions.1, 2, 3 when scratch, prick or puncture reactions are small, or if the patient gives a history of allergic symptoms to a substance but scratch, prick or puncture tests are inconclusive, intradermal tests may be indicated. however, antigens producing large 3 to 4+ scratch, prick or puncture tests should not be tested intradermally. extracts of all allergens do not produce equivalent results in intradermal testing. the intensity of the skin reaction produced will be determined by two factors: the degree of sensitivity of the patient and the nature of the antigenic extract applied. in general, pollen extracts produce whealing reactions, whereas other inhalants produce erythe

TREATMENT SET TS335061 injection, solution
TREATMENT SET TS335100 injection, solution
TREATMENT SET TS335101 injection, soluti 美国 - 英文 - NLM (National Library of Medicine)

treatment set ts335061 injection, solution treatment set ts335100 injection, solution treatment set ts335101 injection, soluti

antigen laboratories, inc. - amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), salsola kali pollen (unii: 2mh135kc6g) (salsola kali pollen - unii:2mh135kc6g), plantago lanceolata pollen (unii: do87t1u2ci) (plantago lanceolata pollen - unii:do87t1u2ci), carya illinoinensis pollen (unii: pyo4jr720y) (carya illinoinensis pollen - unii:pyo4jr720y), carya alba pollen (unii: g2a764t54b) (carya alba pollen - unii:g2a764t54b), juniperus virginiana pollen (unii: py0ja16r2g) (juniperus virg - amaranthus retroflexus pollen 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS335657 injection, solution
TREATMENT SET TS335683 injection, solution 美国 - 英文 - NLM (National Library of Medicine)

treatment set ts335657 injection, solution treatment set ts335683 injection, solution

antigen laboratories, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr), periplaneta americana (unii: 2rq1l9n089) (periplaneta americana - unii:2rq1l9n089), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), juniperus virginiana pollen (unii: py0ja16r2g) - dermatophagoides farinae 400 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS342922 injection, solution 美国 - 英文 - NLM (National Library of Medicine)

treatment set ts342922 injection, solution

antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), acer negundo pollen (unii: p6k070ar8v) (acer negundo pollen - unii:p6k070ar8v), felis catus hair (unii: 1564hd0n96) (felis c - dermatophagoides pteronyssinus 16 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS334946 injection, solution
TREATMENT SET TS334947 injection, solution 美国 - 英文 - NLM (National Library of Medicine)

treatment set ts334946 injection, solution treatment set ts334947 injection, solution

antigen laboratories, inc. - poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia psilostachya pollen (unii: rx18m46k8l) (ambrosia psilostachya pollen - unii:rx18m46k8l), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), plantago lanceolata pollen (unii: do87t1u2ci) (p - poa pratensis pollen 160 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS336437 injection, solution 美国 - 英文 - NLM (National Library of Medicine)

treatment set ts336437 injection, solution

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia psilostachya pollen (unii: rx18m46k8l) (ambrosia psilostachya pollen - unii:rx18m46k8l), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), carya alba pollen (unii: g2a764t54b - alternaria alternata 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski